Innate Pharma SA Issued Capital
Innate Pharma SA (IPHYF) had Issued Capital of EUR 4.69 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:IssuedCapital · last filed 2026-04-01
- 2025-12-31: Issued Capital 4.69M EUR.
- 2025-06-30: Issued Capital 4.61M EUR.
- 2025-04-24: Issued Capital 4.61M EUR.
- 2024-12-31: Issued Capital 4.19M EUR; Issued Capital as first filed 4.19M EUR.
| Period end | Issued Capital | Issued Capital as first filed |
|---|---|---|
| 2025-12-31 | 4.69M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 4.61M EUR 6-K · filed 2025-09-17 | |
| 2025-04-24 | 4.61M EUR 20-F · filed 2026-04-01 | |
| 2024-12-31 | 4.19M EUR 20-F · filed 2026-04-01 | 4.19M EUR 20-F · filed 2025-04-30 |
| 2024-06-30 | 4.05M EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 4.04M EUR 20-F · filed 2026-04-01 | 4.04M EUR 20-F · filed 2024-04-04 |
| 2023-06-30 | 4.03M EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 4.01M EUR 20-F · filed 2025-04-30 | 4.01M EUR 20-F · filed 2023-04-06 |
| 2022-06-30 | 3.99M EUR 6-K · filed 2022-09-15 | |
| 2021-12-31 | 3.98M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 3.95M EUR 6-K · filed 2021-09-15 | |
| 2020-12-31 | 3.95M EUR 20-F · filed 2023-04-06 | |
| 2019-12-31 | 3.94M EUR 20-F · filed 2022-04-04 | 3.94M EUR 20-F · filed 2020-04-24 |
| 2018-12-31 | 3.20M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 2.88M EUR 20-F · filed 2020-04-24 |